110725 Biochemistry Lecture
Overview
Tim Johann explains how competitive, noncompetitive, uncompetitive, and mixed enzyme inhibitors affect apparent Km and Vmax, using Michaelis-Menten and Lineweaver-Burk plots to distinguish their patterns. He then connects enzyme transition-state stabilization to drug design, showing why nonreactive transition-state analogs bind in the active site as competitive inhibitors, with examples from glycolysis and protease chemistry.
Key takeaways
- Competitive inhibitors occupy the active site, increase apparent Km, and leave Vmax unchanged; their Lineweaver-Burk lines share a y-intercept.
- Pure noncompetitive inhibitors bind away from the active site, lower kcat and Vmax, and leave Km unchanged; their Lineweaver-Burk lines share an x-intercept.
- Uncompetitive inhibitors bind the enzyme-substrate complex and lower apparent Km and Vmax by the same fraction, producing parallel Lineweaver-Burk lines.
- Mixed inhibitors change both apparent Km and Vmax, so their Lineweaver-Burk lines are not parallel and do not meet at either axis intercept.
- Transition-state analogs mimic an enzyme's preferred transition-state shape but resist reaction, enabling tight active-site binding as competitive inhibitors.
- For the glycolysis example, compare candidate structures with the transition state for glyceraldehyde 3-phosphate conversion to dihydroxyacetone phosphate to identify a likely analog.
Chapters
- A competitive inhibitor and substrate compete for the same enzyme active site.
- Adding enough substrate can outcompete the inhibitor, so Vmax remains unchanged while more substrate is needed to reach a given rate.
- On a Lineweaver-Burk plot, inhibitor and uninhibited lines share the y-intercept because 1/Vmax is unchanged; apparent Km increases.
- Real experimental data may not intersect perfectly, so inhibitor type should be inferred from the overall pattern rather than an exact crossing.
- A noncompetitive inhibitor binds away from the active site and changes enzyme shape, reducing catalytic turnover, kcat.
- More substrate cannot displace this inhibitor, so the inhibited reaction reaches a lower Vmax.
- For pure noncompetitive inhibition, Km remains unchanged; Lineweaver-Burk lines share the x-intercept at -1/Km.
- The inhibited Lineweaver-Burk line has a larger slope because its lower velocity produces larger 1/v values.
- An uncompetitive inhibitor binds the enzyme-substrate complex, stabilizing substrate binding while making product formation slower.
- Both apparent Km and Vmax decrease by the same fraction, leaving the Lineweaver-Burk slope, Km/Vmax, unchanged.
- The resulting Lineweaver-Burk lines are parallel, with the inhibited line shifted upward and leftward.
- A smaller apparent Km means tighter apparent substrate binding, while a smaller Vmax reflects reduced catalytic turnover.
- An uncompetitive inhibitor shifts the apparent Km to a lower substrate concentration and lowers the Michaelis-Menten curve's plateau, Vmax.
- To estimate Vmax from experimental data, Johann recommends tracing the overall curve and judging where it levels off rather than treating the highest measured point as Vmax.
- The class expects students to estimate kinetic parameters from plotted data, including in the upcoming enzyme-kinetics lab.
- Mixed inhibition combines effects such as binding away from the active site and weakening substrate binding, so both reaction rate and apparent Km can change.
- Mixed-inhibition Lineweaver-Burk lines are neither parallel nor intersecting at the x- or y-intercept.
- Johann notes that mixed inhibition is less visually clean than the idealized patterns for competitive, noncompetitive, and uncompetitive inhibition.
- Enzymes catalyze reactions by binding and stabilizing the transition state more tightly than the substrate, lowering activation energy.
- A molecule that binds the substrate too tightly can raise the barrier to product formation rather than accelerate the reaction.
- A transition-state analog resembles the transition state but does not react, allowing it to remain tightly bound in the active site.
- Because transition-state analogs occupy the active site, they act as competitive inhibitors.
- Johann uses the glycolytic conversion of glyceraldehyde 3-phosphate to dihydroxyacetone phosphate to illustrate transition-state mimicry.
- To identify the strongest candidate inhibitor in a set of compounds, compare each structure with the reaction's transition state.
- The illustrated analog preserves key features of the transition state, including similar hydroxyl and charge arrangements, but uses different chemistry so it does not react.
- A protease hydrolyzes a peptide bond by adding water across it, producing two peptide fragments through a transition state.
- Researchers synthesized and tested several compounds, finding the best transition-state analog by matching important transition-state features.
- The example analog includes hydroxyl groups and a silicon-for-carbon substitution, which helps it resemble the transition state without undergoing the same reaction.
- Johann frames these compounds as competitive inhibitors that bind tightly in the protease active site.
Transcript excerpt
0:00 Then we are we've been talking about enzyme kinetics. You just took a quiz that had enzyme kinetics on it. We're going to we're going to finish that up today. Um we are talking about inhibitors. So last time we talked we were uh or on Wednesday we were talking about there are four types of non-covalent inhibitors and those were competitive non-competitive. What was the other one? Uncompetitive and then mix, which is just a mixture of the ones up above. And we had talked um
0:48 about competitive. I want to review it really quick. Not not as much as we talked about the other day, but competitive inhibitors Competitive inhibitors are going to compete with the substrate for the active site of the enzyme. Oops. Okay. So that's how they work.
1:41 And then when we think about our various graphs, so we have two different graphs that we could do of our kinetic data. We could be graphing um we can do a Michaelis meant plot which would be you vary your substrate you measure that initial rate you'll be doing this next week and you get that initial rate at various substrate concentrations you will get a curve that looks like this um and then from that you know we have a vmax and stuff you can recover the vmax with a competitive inhibitor because you can just add more substrate you add enough substrate it out competes the competitor even if the substrate, the competitor or the inhibitor, even if the inhibitor is really strong binding. So, in other words, it's going to take longer to get to the maximum velocity, but it will still get up there.
2:32 So, this is no inhibitor. Um, and then this is inhibitor. [laughter] And we've talked about how you get a KM
This is the start of the transcript. Save this video free for the whole transcript, searchable and time-coded.
In this course
Related notes
Summary, takeaways, and chapters were generated by AI from the video's transcript and may contain errors. The video belongs to its creator, Tim Johann.